jump to content jump to footer
Research poster presentation on standardized tumor response assessments using mint Lesion at the NCCN Annual Conference 2026

NCCN 2026: Memorial Sloan Kettering Cancer Center Presents Research on Structured Tumor Response Assessments with mint Lesion

Big congratulations to Steven Philemond and Alison Chiaramonte of Memorial Sloan Kettering Cancer Center for presenting their research poster “Use of Electronic Solution Supplemented with Portfolio of Tailored Resources Improves Tumor Response Assessment for Patients” at the recent 2026 NCCN Annual Conference.

Their work dives into how their institutional investment into standardizing clinical trial response assessments leveraging mint Lesion has improved operational efficiency and data quality in real, measurable ways since implementation in 2019:

  • 32% reduction in data deficiencies found during internal audits
  • Principal Investigator use increased from 10% (2019) to 78% (2024)
  • Integration with existing clinical research workflows enhanced inter-disciplinary collaboration

Benefits/Outcomes

Data Integrity

  • Quality: Automated calculations
  • Completeness: Fields of information required before sign-offs
  • Record-keeping: Legibility, timestamps
  • Privacy: Access granted to assessments by administrators
  • Reduction in deficiencies found by internal quality assurance audits

Reduce Administrative Burden

  • Automated back-end processes, such as automatically sending assessments to Epic EMR
  • Radiologist, Investigator, and Study Team user groups avoid using manual methods and sending them around for input and sign-offs
  • Share data with trial sponsors more readily

Ease of Use

  • Define a clear workflow among stakeholders to complete assessments
  • Tumor Response Assessments are housed in one location to improve accessibility for clinical staff and audit preparedness
  • Scalable to accommodate increase in assessment volume as well as new protocol criteria and  unique protocol structures

Financial

  • Bill more accurately for assessments
  • An assessment is never 'lost' and has to be redone

Read the full poster by clicking here.

Mint Medical is proud to support Memorial Sloan Kettering Cancer Centers's mission of ending cancer for life and can't wait to see what they accomplish next.

 If you're looking to transform the intersection of clinical imaging data in cancer research and how Mint Lesion can support your research aspirations, let's talk.

 

 

Success Story mintLesion Clinical Trials Standardized Reading Procedures Data Analysis Therapy Response Assessment Structured Reporting

Related Resources

Radiologists working at workstations analyzing real CT images during an interactive RECIST workshop at ECR 2026
Insights into hands-on RECIST training at ECR 2026: interactive workshops, real cases, and structured reporting with mint Lesion
From Theory to Practice: Hands-On RECIST Training at ECR 2026
This year, Mint Medical contributed to multiple program highlights at the ECR 2026 - bringing together innovation, education, and real-world clinical…
Radiologists reviewing oncologic imaging cases during the ESOI–EORTC Workshop on standardized tumor response assessment
The ESOI–EORTC Workshop provides practical training in RECIST 1.1, standardized tumor response assessment, clinical trial imaging, and hands-on oncology case reviews.
ESOI–EORTC Workshop 2026: Experience, Exchange, and Standardized Tumor Response Assessment in Radiology
The ESOI–EORTC Workshop is one of the leading educational formats for radiologists focusing on the standardized assessment of tumor response.This…
Woman watching the Mint Medical and contextflow webinars on lung cancer screening in Germany on Youtube
Webinar series to explore different aspects of lung cancer screening in Germany
Webinar Series: Lung Cancer Screening in Germany - From Evidence to Implementation
Lung cancer remains one of the leading causes of cancer-related mortality worldwide. In Germany, the introduction of a national lung cancer screening…